Evidence map›Paper›PMID 35335352›Full record

ArticleMolecules (Basel, Switzerland)2022

Dihydrohomoplantagin and Homoplantaginin, Major Flavonoid Glycosides from

Ning Meng, Kai Chen, Yanhong Wang, Jiarong Hou, Wenhui Chu, Shan Xie, Fengying Yang, Chunhui Sun

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Chinese herbal medicines · 2026
    Review
  3. Article
  4. Organelle genome architecture ofFrontiers in plant science · 2026
    Article
  5. Article
  6. The essential oil from the rhizomes ofFrontiers in pharmacology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ning MengSchool of Biological Science and Technology, University of Jinan, Jinan 250022, China.
Kai ChenNew Drug Evaluation Center, Shandong Academy of Pharmaceutical Sciences, Jinan 250101, China.
Yanhong WangSchool of Biological Science and Technology, University of Jinan, Jinan 250022, China.
Jiarong HouSchool of Biological Science and Technology, University of Jinan, Jinan 250022, China.
Wenhui ChuSchool of Biological Science and Technology, University of Jinan, Jinan 250022, China.
Shan XieSchool of Biological Science and Technology, University of Jinan, Jinan 250022, China.
Fengying YangNew Drug Evaluation Center, Shandong Academy of Pharmaceutical Sciences, Jinan 250101, China.
Chunhui SunInstitute for Advanced Interdisciplinary Research (iAIR), University of Jinan, Jinan 250022, China.
University of Jinan · CNShandong Academy of Pharmaceutical Sciences · CN

Funding

National Natural Science Foundation of China 21602076Natural Science Foundation of Shandong Province ZR2020YQ52Project of Shandong Province Higher Educational Youth Innovation Science and Technology Program 2020KJE006
6 · The paper itself

Abstract

Oxidized low-density lipoprotein (oxLDL)-induced endothelium injury promotes the development of atherosclerosis. It has been reported that homoplantaginin, a flavonoid glycoside from the traditional Chinese medicine

Indexed as

AtherosclerosisSalviaAnimalsEndothelial CellsEndotheliumFlavonoidsGlucosidesGlycosidesLipoproteins, LDLMiceNF-E2-Related Factor 2Signal Transduction6-methoxy-4',5-dihydroxyflavone-7-O-glucosideFlavonoidsGlucosidesGlycosidesLipoproteins, LDLNF-E2-Related Factor 2oxidized low density lipoproteinatherosclerosishomoplantagininNrf2oxidized low-density lipoproteinvascular endothelial cell

Identifiers

PMID35335352
PMCPMC8951125
OpenAlexW4221005488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.